Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis

Virology

Volumn 401, Issue 1, 2010, Pages 49-60

  D'Costa, Susan M ^a   Bainbridge, Travis W ^a,b   Kato, Sayuri E ^a   Prins, Cindy ^a,c   Kelley, Karen ^a   Condit, Richard C ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b GENENTECH INC   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

DNA replication; H5; Postreplicative gene transcription; Poxvirus; Scaffold; Ts; Vaccinia; Virion morphogenesis

Indexed keywords

H5 PROTEIN; MESSENGER RNA; RIFAMPICIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; DNA TRANSCRIPTION; GENE EXPRESSION; GENE MAPPING; GENETIC TRANSCRIPTION; IN VIVO STUDY; MORPHOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA METABOLISM; TEMPERATURE SENSITIVITY; VACCINIA VIRUS; VIRION; VIRUS MUTANT; VIRUS REPLICATION;

DNA REPLICATION; DNA, VIRAL; DNA-BINDING PROTEINS; HUMANS; TRANSCRIPTION, GENETIC; VACCINIA VIRUS; VIRAL PROTEINS; VIRION; VIRUS REPLICATION;

POXVIRIDAE;

EID: 77950957089     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.01.020     Document Type: Article

References (46)

1. Bayliss C.D., Condit R.C. The vaccinia virus A18R gene product is a DNA-dependent ATPase. J. Biol. Chem. 1995, 270:1550-1556.
2. Beaud G., Beaud R. Temperature-dependent phosphorylation state of the H5R protein synthesised at the early stage of infection in cells infected with vaccinia virus ts mutants of the B1R and F10L protein kinases. Intervirology 2000, 43:67-70.
3. Beaud G., Sharif A., Topa-Masse A., Leader D.P. Ribosomal protein S2/Sa kinase purified from HeLa cells infected with vaccinia virus corresponds to the B1R protein kinase and phosphorylates in vitro the viral ssDNA-binding protein. J. Gen. Virol. 1994, 75(Pt 2):283-293.
4. Beaud G., Beaud R., Leader D.P. Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase. J. Virol. 1995, 69:1819-1826.
5. Black E.P., Moussatche N., Condit R.C. Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R. Virology 1998, 245:313-322.
6. Condit R.C., Motyczka A. Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology 1981, 113:224-241.
7. Condit R.C., Niles E.G. Regulation of viral transcription elongation and termination during vaccinia virus infection. Biochim. Biophys. Acta 2002, 1577:325-336.
8. Condit R.C., Motyczka A., Spizz G. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology 1983, 128:429-443.
9. Condit R.C., Lewis J.I., Quinn M., Christen L.M., Niles E.G. Use of lysolecithin-permeabilized infected-cell extracts to investigate the in vitro biochemical phenotypes of poxvirus ts mutations altered in viral transcription activity. Virology 1996, 218:169-180.
10. Condit R.C., Moussatche N., Traktman P. In a nutshell: structure and assembly of the vaccinia virion. Adv. Virus Res. 2006, 66:31-124.
11. Cresawn S.G., Condit R.C. A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription. Virology 2007, 363:333-341.
12. Dales S., Milovanovitch V., Pogo B.G., Weintraub S.B., Huima T., Wilton S., McFadden G. Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects. Virology 1978, 84:403-428.
13. D'Costa S.M., Antczak J.B., Pickup D.J., Condit R.C. Post-transcription cleavage generates the 3′ end of F17R transcripts in vaccinia virus. Virology 2004, 319:1-11.
14. D'Costa S.M., Bainbridge T.W., Condit R.C. Purification and properties of the vaccinia virus mRNA processing factor. J. Biol. Chem. 2008, 283:5267-5275.
15. Dellis S., Strickland K.C., McCarry W.J., Patel A., Stocum E., Wright C.F. Protein interactions among the vaccinia virus late transcription factors. Virology 2004, 329:328-336.
16. Demasi J., Traktman P. Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis. J. Virol. 2000, 74:2393-2405.
17. Fuerst T.R., Niles E.G., Studier F.W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:8122-8126.
18. Gordon J., Mohandas A., Wilton S., Dales S. A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope. Virology 1991, 181:671-686.
19. Ishii K., Moss B. Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants. J. Virol. 2001, 75:1656-1663.
20. Ishii K., Moss B. Mapping interaction sites of the A20R protein component of the vaccinia virus DNA replication complex. Virology 2002, 303:232-239.
21. Kato S.E., Condit R.C., Moussatche N. The vaccinia virus E8R gene product is required for formation of transcriptionally active virions. Virology 2007, 367:398-412.
22. Kato S.E., Moussatche N., D'Costa S.M., Bainbridge T.W., Prins C., Strahl A.L., Shatzer A.N., Brinker A.J., Kay N.E., Condit R.C. Marker rescue mapping of the combined Condit/Dales collection of temperature-sensitive vaccinia virus mutants. Virology 2008, 375:213-222.
23. Kovacs G.R., Moss B. The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression. J. Virol. 1996, 70:6796-6802.
24. Lackner C.A., D'Costa S.M., Buck C., Condit R.C. Complementation analysis of the dales collection of vaccinia virus temperature-sensitive mutants. Virology 2003, 305:240-259.
25. Latner D.R., Xiang Y., Lewis J.I., Condit J., Condit R.C. The vaccinia virus bifunctional gene J3 (nucleoside-2′-O-)- methyltransferase and poly(A) polymerase stimulatory factor is implicated as a positive transcription elongation factor by two genetic approaches. Virology 2000, 269:345-355.
26. Luttge B.G., Moyer R.W. Suppressors of a host range mutation in the rabbitpox virus serpin SPI-1 map to proteins essential for viral DNA replication. J. Virol. 2005, 79:9168-9179.
27. McCraith S., Holtzman T., Moss B., Fields S. Genome-wide analysis of vaccinia virus protein-protein interactions. Proc. Natl. Acad. Sci. U.S.A 2000, 97:4879-4884.
28. McDonald W.F., Crozel-Goudot V., Traktman P. Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression. J. Virol. 1992, 66:534-547.
29. Mercer J., Traktman P. Genetic and cell biological characterization of the vaccinia virus A30 and G7 phosphoproteins. J. Virol. 2005, 79:7146-7161.
30. Moss B. Poxviridae: the viruses and their replication. Fields Virology 2007, 2906-2945. Wolters, Kluwer-Lippincott, Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
31. Nowakowski M., Bauer W., Kates J. Characterization of a DNA-binding phosphoprotein from vaccinia virus replication complex. Virology 1978, 86:217-225.
32. Punjabi A., Traktman P. Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis. J. Virol. 2005, 79:2171-2190.
33. Rempel R.E., Traktman P. Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins. J. Virol. 1992, 66:4413-4426.
34. Romero P., Obradovic Z., Dunker A.K. Natively disordered proteins: functions and predictions. Appl. Bioinformatics 2004, 3:105-113.
35. Rosel J.L., Earl P.L., Weir J.P., Moss B. Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment. J. Virol. 1986, 60:436-449.
36. Shatzer A.N., Kato S.E., Condit R.C. Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme. Virology 2008, 375:236-252.
37. Sridhar P., Condit R.C. Selection for temperature-sensitive mutations in specific vaccinia virus genes: isolation and characterization of a virus mutant which encodes a phosphonoacetic acid-resistant, temperature-sensitive DNA polymerase. Virology 1983, 128:444-457.
38. Stanitsa E.S., Arps L., Traktman P. Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase. J. Biol. Chem. 2006, 281:3439-3451.
39. Szajner P., Jaffe H., Weisberg A.S., Moss B. A complex of seven vaccinia virus proteins conserved in all chordopoxviruses is required for the association of membranes and viroplasm to form immature virions. Virology 2004, 330:447-459.
40. Szajner P., Weisberg A.S., Lebowitz J., Heuser J., Moss B. External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice. J. Cell Biol. 2005, 170:971-981.
41. Traktman P., Boyle K. Methods for analysis of poxvirus DNA replication. Methods Mol. Biol. 2004, 269:169-186.
42. Traktman P., Caligiuri A., Jesty S.A., Liu K., Sankar U. Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J. Virol. 1995, 69:6581-6587.
43. Unger B., Traktman P. Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions. J. Virol. 2004, 78:8885-8901.
44. Wang S., Shuman S. Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J. Virol. 1995, 69:6376-6388.
45. Wiebe M.S., Traktman P. Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication. Cell Host. Microbe 2007, 1:187-197.
46. Yao X.D., Evans D.H. High-frequency genetic recombination and reactivation of orthopoxviruses from DNA fragments transfected into leporipoxvirus-infected cells. J. Virol. 2003, 77:7281-7290.